Warning: members of the public are being contacted by people claiming to work for AXA Investment Managers UK Limited.  Find out more information and what to do by clicking here.

Robotech strategy - December 2021

  • 10 January 2022 (5 min read)

Inflationary pressures and supply chain challenges present an opportunity for automation

  • The markets capped a year of strong returns for global equities
  • We saw particular strength in our Healthcare and Industrial holdings
  • We topped up a number of companies in the strategy during the month

What’s happening?

Equity markets rose during December (MSCI ACWI Index in USD terms), capping a year of strong returns for global equities.  The Robotech strategy modestly underperformed the broader market during the month.  Corporate news flow was more limited towards the end of the year, but later in January, we will be hearing companies report their calendar Q4 earnings and provide commentary and outlooks for 2022.

As we look to 2022, we continue to believe that inflationary pressures and supply chain challenges will continue to have an impact on companies operations as well as labour shortages in certain parts of the economy contributing to rising wage pressure.  According to the US JOLTS figures (Job Openings and Labour Turnover Survey), there are around 11 million jobs that are currently being advertised for in the US compared to  6-7 million which was the average in the years pre-pandemic1 .  This high level of job openings indicates that companies are trying to source employees, but are struggling to find them.  In many industries, labour scarcity presents an opportunity for automation to help ease these pressures, particularly in areas like manufacturing and we see this being a key driver of automation demand whilst these issues persist.

Portfolio positioning and performance

We saw particular strength during the month in our Healthcare and Industrial holdings.  Robotic surgery specialist Intuitive Surgical performed well as did Globus Medical – a specialist in spinal surgery.  Japanese industrial robotics companies Fanuc and Yaskawa performed well, as CAPEX2 trends appear supportive for robotic demand in 2022.  European Industrial companies Siemens and Schneider Electric performed well.

Performance was mixed across our semiconductor holdings, with Ambarella, Teradyne and On Semiconductor performing well.  On Semiconductor is benefitting from the strong demands for chips coming from the automotive and industrial sectors, and, at the same time, like many of its peers, is able to secure long term supply agreements with its customers as a result of the current industry shortages.  AMD and Nvidia, semiconductor companies exposed to Artificial Intelligent and High performance computing, were softer during the month as investors took profits following a very strong year of performance – notably with Nvidia’s share price increasing 125% over the last 12 months3 .

We topped up a number of companies in the strategy during the month, notably companies exposed to warehouse automation, including: GXO Logistics – an automated warehousing specialist, Cognex – a manufacturer of cameras used for automation, Daifuku – a Japanese company focused on material handling solutions and Amazon.  We also added to several healthcare related companies including Align, Globus Medical and Axonics.  We increased our position in Kornit Digital, which was a new addition to the portfolio in November.

Having reduced our position in PTC (US software company focused on CAD and IoT) in November, we exited it during December.  We took some profits from our position in Ambarella (a semiconductor company focused on computer vision) and Quidel (a diagnostics company).


The topic of inflation continues to be a source of debate both as to the magnitude and potential duration of its impact.  It is ultimately hard to forecast the effect here, due to the unpredictability associated with the ongoing COVID pandemic and Omicron wave.  It is worth paying attention to the recent and rapid wage inflation that is being seen in parts of the economy, notably warehousing employees.  Warehousing is one of the areas that is seeing the large labour challenges at the moment.  The growth of ecommerce, both long term structural growth of the industry, coupled with the additional surge seen during the pandemic, has accelerated the shift to online consumption which likely leads to a large increase in demand for automation technologies associated with warehousing and logistics.  We have long invested in this space in the Robotech strategy, with companies like Kion & Daifuku (material handling solutions), Cognex & Keyence (vision systems) and Ocado (Automated Grocery).  In 2021 we added two new names to the portfolio that are also exposed to this trend - GXO Logistics (warehouse operator specialising in automation) and Autostore (a manufacturer of automated storage and retrieval solutions for warehouses).

The labour shortages and wage increases impact many other parts of the economy outside of warehousing.  When labour cannot be appropriately sourced, or when the cost of labour is increasing, it can make investments in automation more attractive – with quicker payback periods and less risk.  As the economics of adopting automation become more compelling, coupled with technology improvements which broaden the range of what can be automated – we see demand for automation equipment sustaining.

At the end of October, The International Federation of Robotics, a leading industry research group that track deployments of industrial robots around the world, released their figures of industrial robot deployments.  This confirmed, that despite the disruption seen by COVID, shipments of industrial robots were higher in 2020 than in 2019.  They also released their forecasts for robot installations out to 2024 which showed continued solid growth for the industry.  We are optimistic for the growth of Robotics over the coming years - in addition to the pent up demand for automation equipment post COVID-19, we believe that there are also elements of pent up demand coming thorough post the US China trade war of 2019/2020 – we were starting to see signs of this recovery at the end of 2019 and early 2020 before COVID put companies investment plans on hold.  If this does start to materialise, this could signal a more prolonged period of higher industrial activity and CAPEX investments, supportive to a range of automation companies.

No assurance can be given that the Robotech Strategy will be successful. Investors can lose some or all of their capital invested. The Robotech strategy is subject to risks including; Equity; Emerging markets; Investments in specific sectors or asset classes; Global investments; Investments in small and/or micro capitalisation universe; ESG.

  • U291cmNlOiBCbG9vbWJlcmcgYXMgb2YgMzEvMTAvMjE=
  • U291cmNlOiBCbG9vbWJlcmcgYXMgb2YgMzEvMTIvMjAyMQ==
Read the full article
Download report (255.18 KB)

Related Articles


Robotics sector looks primed for further growth in 2024


Taking stock of 2023: Tech Update

  • by AXA Investment Managers
  • 21 December 2023 (5 min read)

Global Thematics strategy - February 2023

  • by David Shaw, Mark Hargraves
  • 21 February 2023 (5 min read)


    Not for Retail distribution: This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

    Past performance is not a guide to current or future performance, and any performance or return data displayed does not take into account commissions and costs incurred when issuing or redeeming units. The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. Exchange-rate fluctuations may also affect the value of their investment.  Due to this and the initial charge that is usually made, an investment is not usually suitable as a short term holding.

    This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities. The strategies discussed in this document may not be available in your jurisdiction.

    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    Please note that the management company reserves the right, at any time, to no longer market the product(s) mentioned in this communication in an European Union country by notification to its authority of supervision in accordance with European passport rules. In the event of dissatisfaction with the products or services, you have the right to make a complaint either with the marketer or directly with the management company (more information on our complaints policy available in English here). You also have the right to take legal or extra-judicial action at any time if you reside in one of the countries of the European Union. The European online dispute resolution platform allows you to enter a complaint form (by clicking here) and informs you, depending on your jurisdiction, about your means of redress (by clicking here).

    Issued in the U.K. by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales, No: 01431068. Registered Office: 22 Bishopsgate, London, EC2N 4BQ. In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.

    Risk Warning

    The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. 

    Are you an IFA or other Professional Investor ?

    Are you a financial advisor, institutional, or other professional investor?

    This section is for professional investors only. You need to confirm that you have the required investment knowledge and experience to view this content. This includes understanding the risks associated with investment products, and any other required qualifications according to the rules of your jurisdiction.